CA2678131A1 - Distribution colique a l'aide de billes zn/pectine avec un revetement d'eudragit - Google Patents

Distribution colique a l'aide de billes zn/pectine avec un revetement d'eudragit Download PDF

Info

Publication number
CA2678131A1
CA2678131A1 CA002678131A CA2678131A CA2678131A1 CA 2678131 A1 CA2678131 A1 CA 2678131A1 CA 002678131 A CA002678131 A CA 002678131A CA 2678131 A CA2678131 A CA 2678131A CA 2678131 A1 CA2678131 A1 CA 2678131A1
Authority
CA
Canada
Prior art keywords
human
drug delivery
agents
agent
delivery system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002678131A
Other languages
English (en)
Inventor
Antoine Andremont
Helene-Celine Huguet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Da Volterra SAS
Original Assignee
Antoine Andremont
Helene-Celine Huguet
Da Volterra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antoine Andremont, Helene-Celine Huguet, Da Volterra filed Critical Antoine Andremont
Publication of CA2678131A1 publication Critical patent/CA2678131A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
CA002678131A 2006-11-17 2007-11-16 Distribution colique a l'aide de billes zn/pectine avec un revetement d'eudragit Abandoned CA2678131A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85960006P 2006-11-17 2006-11-17
US85959906P 2006-11-17 2006-11-17
US60/859,600 2006-11-17
US60/859,599 2006-11-17
PCT/EP2007/062475 WO2008059062A1 (fr) 2006-11-17 2007-11-16 Distribution colique à l'aide de billes zn/pectine avec un revêtement d'eudragit

Publications (1)

Publication Number Publication Date
CA2678131A1 true CA2678131A1 (fr) 2008-05-22

Family

ID=39181811

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002678131A Abandoned CA2678131A1 (fr) 2006-11-17 2007-11-16 Distribution colique a l'aide de billes zn/pectine avec un revetement d'eudragit

Country Status (7)

Country Link
EP (1) EP2081557A1 (fr)
JP (1) JP2010510196A (fr)
CN (1) CN101795675A (fr)
AU (1) AU2007321111A1 (fr)
BR (1) BRPI0719319A2 (fr)
CA (1) CA2678131A1 (fr)
WO (1) WO2008059062A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009043527A2 (fr) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
RU2010114058A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение пептида в качестве терапевтического средства
AU2008303942A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of BFGF 1-24 and optionally (ARG 8) vasopressin to treat eg S. pneumoniae infection
CZ302789B6 (cs) 2009-11-25 2011-11-09 Zentiva, K. S. Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
ES2586135T3 (es) * 2010-02-23 2016-10-11 Da Volterra Formulaciones para el suministro oral de adsorbentes en el intestino
BR112012024877A2 (pt) * 2010-04-08 2016-06-14 Merz Pharma Gmbh & Co Kgaa preenchedor, processo para o preparo de um preenchedor e dispositivo de injeção
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
JP6464142B2 (ja) * 2013-03-14 2019-02-06 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
JP6522584B2 (ja) * 2013-04-26 2019-05-29 ラ ホヤ ファーマシューティカル カンパニーＬａ Ｊｏｌｌａ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏｍｐａｎｙ 腎不全を処置するための組成物及び方法
WO2015066212A2 (fr) * 2013-10-31 2015-05-07 University Of Hawaii Inhibiteurs de la calpaïne destinés au traitement de la maladie inflammatoire chronique de l'intestin et du cancer colorectal
EP3607962A1 (fr) 2013-12-18 2020-02-12 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotensine ii seule ou en association pour le traitement de l'hypotension
WO2015091885A2 (fr) 2013-12-20 2015-06-25 Fresenius Kabi Deutschland Gmbh Microcapsules avec un revêtement polymère comprenant un lipide et un agent actif
DK3191083T3 (da) * 2014-09-11 2021-04-19 Gelita Ag Gelatine-/pektinpartikler
US20160158174A1 (en) * 2014-12-09 2016-06-09 Intercontinental Great Brands Llc Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients
EP3400000B1 (fr) 2016-01-07 2023-12-06 La Jolla Pharma, LLC Méthodes d'administration d'angiotensine ii
US11517614B2 (en) * 2016-06-28 2022-12-06 Synthetic Biologics, Inc. Microbiome protection from oral antibiotics
US11771656B2 (en) * 2016-11-17 2023-10-03 Shanghai Jiaotong University School Of Medicine Oral colon-targeted delivery system and preparation method and application thereof
DE102017000896A1 (de) * 2017-02-01 2018-08-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Selektives Freisetzungssystem für Tumortherapeutika und Tumordiagnostika sowie Biosensor für Tumorgewebe
WO2018191678A1 (fr) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Méthodes d'administration d'angiotensine ii

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
RU2375047C2 (ru) * 2004-03-26 2009-12-10 Лек Фармасьютиклз Д.Д. Фармацевтическая лекарственная форма, устойчивая к действию желудочного сока, включающая n-(2-(2-фталимидоэтокси)ацетил)-l-аланил-d-глутаминовую кислоту (lk 423)
JP2008540602A (ja) * 2005-05-18 2008-11-20 ダ・ボルテラ 吸着剤の結腸送達

Also Published As

Publication number Publication date
AU2007321111A1 (en) 2008-05-22
WO2008059062A1 (fr) 2008-05-22
CN101795675A (zh) 2010-08-04
JP2010510196A (ja) 2010-04-02
BRPI0719319A2 (pt) 2014-02-04
EP2081557A1 (fr) 2009-07-29

Similar Documents

Publication Publication Date Title
CA2678131A1 (fr) Distribution colique a l'aide de billes zn/pectine avec un revetement d'eudragit
US20080124279A1 (en) Colonic delivery using Zn/pectin beads with a Eudragit coating
US20080317666A1 (en) Colonic Delivery of Active Agents
KR101080577B1 (ko) 활성성분의 결장 표적화 전달을 위한 제제
KR0157280B1 (ko) 하부소화관 방출성의 경구의약제제
JP2002521346A (ja) 多糖類を利用した大腸選択性薬物伝達組成物および医薬製剤
KR20190127984A (ko) 지연 방출형 약물 제형
Prasanth et al. Colon specific drug delivery systems: a review on various pharmaceutical approaches
RU2282462C2 (ru) Композиции и способы улучшения перорального всасывания противомикробных средств
JP2013525351A (ja) ナノ粒子の医薬組成物
US8273376B2 (en) Colonic delivery of metallo-dependent enzymes
Gupta A review article on colonic targeted drug delivery system
EP3737750A1 (fr) Agents de phosphatase alcaline pour le traitement de troubles neurodéveloppementaux
US20220202721A1 (en) Articles and methods for administration of therapeutic agents
Patel et al. Colon targeted drug delivery: Approaches and newer technology
US20220257726A1 (en) Intestinal alkaline phosphatase-based treatments of metabolic disorders
Jangde Colonic drug delivery of new approaches
AU2002300676B2 (en) A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
Goracinova et al. Drug targeting in IBD treatment–Existing and new approaches

Legal Events

Date Code Title Description
FZDE Dead